Whitehouse Station, NJ, United States of America

Matthew J Marton

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2018-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew J Marton. Retrieved from https://idiyas.com/inventor/matthew-j-marton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Matthew J Marton

Introduction

Matthew J Marton is an accomplished inventor based in Whitehouse Station, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Marton is dedicated to advancing medical science and improving patient outcomes.

Latest Patents

Marton's latest patents focus on methods for treating cancer using specific inhibitors. One of his notable inventions is titled "Methods for treating cancer with a WEE1 inhibitor." This invention relates to the use of gene mutations to predict a patient's response to treatment with an anti-proliferative agent, particularly a WEE1 inhibitor. The presence or absence of a mutation in the TP53 gene can be instrumental in predicting how a patient with a cancerous condition will respond to this treatment.

Another significant patent is "Methods and compositions for treating cancer by identifying one or more ERK mutations." This invention encompasses methods, reagents, and kits for detecting MAPK/ERK pathway mutations in cancer patients. It includes a sensitive and selective method to identify mutations in the BRAF, KRAS, and NRAS genes in a single reaction. Additionally, it provides primers and probes for detecting these mutations using a single nucleotide primer extension assay, which can help identify patients suitable for treatment with an ERK inhibitor.

Career Highlights

Matthew J Marton is currently employed at Merck Sharp & Dohme Corp., where he continues to work on innovative solutions in cancer treatment. His expertise and dedication to research have positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Marton has collaborated with notable colleagues, including Yair Benita and Ken C N Chang. These collaborations have further enhanced his research and contributed to the development of effective cancer treatments.

Conclusion

Matthew J Marton is a pioneering inventor whose work in cancer treatment is making a significant impact. His innovative patents and dedication to research exemplify the importance of advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…